Fig. 6From: A novel prostaglandin I2 agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model miceEffects of ONO-1301 against Human umbilical vein vascular endothelial cells (HUVECs) in vitro. A After addition of ONO-1301 (0.1 μM) or vehicle to HUVEC cultures, mRNA expression levels of Hgf, Vegf, and Sdf1 were analyzed (each experiment was repeated six times). B cAMP levels of each condition were analyzed of three independent experiments. Data are presented as means ± standard deviations. ns: not significantBack to article page